# Prognostic Impact of C-reactive Protein-Albumin-Lymphocyte Index in Patients Who Underwent Splenectomy and Devascularization for Gastric Varices Caused by Portal Hypertension

**Authors:** Ko Oshita, Tsuyoshi Kobayashi, Naruhiko Honmyo, Seiichi Shimizu, Shintaro Kuroda, Hiroyuki Tahara, Masahiro Ohira, Kentaro Ide, Hideki Ohdan

PMC · DOI: 10.7759/cureus.87092 · Cureus · 2025-07-01

## TL;DR

This study shows that a new blood-based score, the CALLY index, can predict survival outcomes in patients undergoing surgery for gastric varices caused by portal hypertension.

## Contribution

The study introduces the CALLY index as a novel prognostic tool for surgical patients with gastric varices.

## Key findings

- A low CALLY index was significantly associated with worse overall survival in patients undergoing surgery for gastric varices.
- Multivariate analysis confirmed the CALLY index as an independent risk factor for poor survival outcomes.
- Low CALLY patients had higher portal vein pressure after surgery compared to high CALLY patients.

## Abstract

Purpose: The C-reactive protein-albumin-lymphocyte (CALLY) index is a novel nutritional and inflammation-based index. This study aimed to evaluate the prognostic value of the preoperative CALLY index in patients who underwent splenectomy and devascularization (Sp + Dev) for gastric varices caused by portal hypertension.

Methods: This study included 64 patients who underwent Sp + Dev for gastric varices between January 2009 and March 2022. The CALLY index was calculated as (albumin × lymphocyte)/(C-reactive protein × 104), and the patients were divided into high and low CALLY groups. Log-rank tests were performed to compare the overall survival (OS). Independent risk factors for OS were identified by multivariate analysis. Propensity score-matching was performed for survival analysis to balance the selection bias for stratification of the CALLY index.

Results: The cut-off value of the CALLY index was set at 4.35 using receiver-operating characteristic curve analysis, and 39 patients were classified into the low CALLY group. The low CALLY group had significantly worse OS (p = 0.013) than the high CALLY group. Multivariate analysis identified a low CALLY index (hazard ratio (HR) = 3.787; 95% confidence interval (CI) = 1.174-12.218; p = 0.026) and concurrent hepatocellular carcinoma (HR = 2.914; 95% CI = 1.018-8.342; p = 0.046) as independent risk factors for poor OS. After propensity score-matching to balance the selection bias, a low CALLY index significantly correlated with worse OS (p = 0.026). The low CALLY group had significantly worse portal vein pressure after splenectomy than the high CALLY group (p = 0.031).

Conclusions: Preoperative CALLY index is a significant prognostic indicator for gastric varices after Sp + Dev. The CALLY index may be useful in determining the suitability of surgical treatment and perioperative management.

## Linked entities

- **Proteins:** LOC100189571 (uncharacterized LOC100189571)
- **Diseases:** portal hypertension (MONDO:0005080), hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** hypersplenism (MESH:D006971), portal vein thrombosis (MESH:D012170), death (MESH:D003643), HCC (MESH:D006528), Child (MESH:C562515), GVs (MESH:D004932), Portal Hypertension (MESH:D006975), blood loss (MESH:D016063), varicose veins (MESH:D014648), viral hepatitis (MESH:D014777), liver cirrhosis (MESH:D008103), hepatitis (MESH:D056486), liver disease (MESH:D008107), bacterial infections (MESH:D001424), NLR (MESH:D015467), TNM (MESH:D008207), ascites (MESH:D001201), metastasis (MESH:D009362), diabetes mellitus (MESH:D003920), immune dysfunction (MESH:D007154), MELD (MESH:D058625), cancer (MESH:D009369), SI (MESH:D007249), blood (MESH:D006402), thrombocytopenia (MESH:D013921), cirrhosis (MESH:D005355), rupture (MESH:D012421)
- **Chemicals:** bilirubin (MESH:D001663), Sp (MESH:C000604007), carbon dioxide (MESH:D002245), Dev (-), creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606], hepatitis C virus [taxon 11103]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12312047/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12312047/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12312047/full.md

---
Source: https://tomesphere.com/paper/PMC12312047